The modulating effect of differences in cardiovascular risk factors on major cardiovascular outcomes in glucose-lowering trials: 'good to know' but not the whole story

J Hypertens. 2019 Oct;37(10):1959-1960. doi: 10.1097/HJH.0000000000002181.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Blood Pressure
  • Cardiovascular Diseases*
  • Diabetes Mellitus*
  • Glucose
  • Humans
  • Hypoglycemic Agents
  • Incidence
  • Randomized Controlled Trials as Topic
  • Risk Factors

Substances

  • Hypoglycemic Agents
  • Glucose